Spitler L E
Clin Exp Immunol. 1980 Mar;39(3):708-16.
Transfer factor was prepared from highly selected normal donors. One lot was made from donors strongly reactive to coccidioidin and negative to Dharmendra antigen in in vivo and in vitro testing. The other lot was made from donors without reactivity to coccidioidin and strongly reactive to Dharmendra. Aliquots of each lot were injected into eight normal recipients. Eight additional normal recipients were given placebo injections. Before and after injection, skin test reactivity and in vitro testing were evaluated by an individual who did not know which preparation the patient received. Changes in immunologic reactivity in subjects receiving transfer factor could not be distinguished from those in subjects receiving placebo. I conclude that transfer factor does not cause enhancement of immunologic reactivity in normal subjects. A well designed, critical study is needed to determine whether or not it does, in fact, cause enhancement of immunologic reactivity in patients with impaired cellular immune reactivity.
转移因子是从经过严格挑选的正常供体中制备的。一批转移因子来自于在体内和体外测试中对球孢子菌素强烈反应且对达门德拉抗原呈阴性的供体。另一批转移因子来自于对球孢子菌素无反应且对达门德拉强烈反应的供体。将每批转移因子的等分试样注射到八名正常接受者体内。另外八名正常接受者接受安慰剂注射。在注射前后,由一名不知道患者接受哪种制剂的人员评估皮肤试验反应性和体外测试。接受转移因子的受试者的免疫反应性变化与接受安慰剂的受试者无法区分。我得出结论,转移因子不会导致正常受试者免疫反应性增强。需要进行一项设计良好的严谨研究来确定它实际上是否会导致细胞免疫反应受损患者的免疫反应性增强。